Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDegLira vs Premixed Insulin in T2D
NCT06408532Phase 4Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Apr 2024
- Primary completion
- Oct 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of insulin degludec + liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Peking University People's Hospital. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
insulin degludec + liraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06408532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06408532.